{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:39:55Z","timestamp":1790642395966,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,16]]},"DOI":"10.7759\/cureus.40527","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T17:50:29Z","timestamp":1686937829000},"source":"Crossref","is-referenced-by-count":2,"title":["An Analysis of the Usage of Retinal Imaging Technology in the Detection of Age-Related Macular Degeneration"],"prefix":"10.7759","author":[{"given":"Parsa","family":"Riazi Esfahani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay J","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillon  A","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Farasat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel","family":"Nawathey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Bachir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Telak","family":"Brahmbhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong WL","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014, 2:e106-16. 10.1016\/S2214-109X(13)70145-1","journal-title":"Lancet Glob Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1109\/TMI.2019.2927226","article-title":"A large-scale database and a CNN model for attention-based glaucoma detection","volume":"39","author":"Li L","year":"2020","unstructured":"Li L, Xu M, Liu H, et al.. A large-scale database and a CNN model for attention-based glaucoma detection. IEEE Trans Med Imaging. 2020, 39:413-24. 10.1109\/TMI.2019.2927226","journal-title":"IEEE Trans Med Imaging"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim LS","year":"2012","unstructured":"Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012, 379:1728-38. 10.1016\/S0140-6736(12)60282-7","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17579","article-title":"Clinical wide-field retinal image deep learning classification of exudative and non-exudative age-related macular degeneration","volume":"13","author":"Tak N","year":"2021","unstructured":"Tak N, Reddy AJ, Martel J, Martel JB. Clinical wide-field retinal image deep learning classification of exudative and non-exudative age-related macular degeneration. Cureus. 2021, 13:e17579. 10.7759\/cureus.17579","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-018-0124-5","article-title":"Imaging retinal melanin: a review of current technologies","volume":"12","author":"Lapierre-Landry M","year":"2018","unstructured":"Lapierre-Landry M, Carroll J, Skala MC. Imaging retinal melanin: a review of current technologies. J Biol Eng. 2018, 12:29. 10.1186\/s13036-018-0124-5","journal-title":"J Biol Eng"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2017.10.014","article-title":"Real study: re-treatment evaluated on visual acuity for Lucentis(\u00ae) in neovascular AMD","volume":"41","author":"Bellocq D","year":"2018","unstructured":"Bellocq D, De Bats F, Rabilloud M, Kodjikian L. Real study: re-treatment evaluated on visual acuity for Lucentis(\u00ae) in neovascular AMD. J Fr Ophtalmol. 2018, 41:397-401. 10.1016\/j.jfo.2017.10.014","journal-title":"J Fr Ophtalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31109-x","article-title":"Correlation of color fundus photograph grading with risks of early age-related macular degeneration by using automated OCT-derived drusen measurements","volume":"8","author":"Cheung CM","year":"2018","unstructured":"Cheung CM, Shi Y, Tham YC, et al.. Correlation of color fundus photograph grading with risks of early age-related macular degeneration by using automated OCT-derived drusen measurements. Sci Rep. 2018, 8:12937. 10.1038\/s41598-018-31109-x","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-017-3888-2","article-title":"Subfoveal choroidal thickness predicts macular atrophy in age-related macular degeneration: results from the TREX-AMD trial","volume":"256","author":"Fan W","year":"2018","unstructured":"Fan W, Abdelfattah NS, Uji A, Lei J, Ip M, Sadda SR, Wykoff CC. Subfoveal choroidal thickness predicts macular atrophy in age-related macular degeneration: results from the TREX-AMD trial. Graefes Arch Clin Exp Ophthalmol. 2018, 256:511-8. 10.1007\/s00417-017-3888-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4114","article-title":"Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration","volume":"36","author":"da Cruz L","year":"2018","unstructured":"da Cruz L, Fynes K, Georgiadis O, et al.. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat Biotechnol. 2018, 36:328-37. 10.1038\/nbt.4114","journal-title":"Nat Biotechnol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-311865","article-title":"Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial","volume":"103","author":"Freiberg FJ","year":"2019","unstructured":"Freiberg FJ, Michels S, Muldrew A, et al.. Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial. Br J Ophthalmol. 2019, 103:469-74. 10.1136\/bjophthalmol-2018-311865","journal-title":"Br J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.09.015","article-title":"Subthreshold nanosecond laser intervention in age-related macular degeneration: the LEAD randomized controlled clinical trial","volume":"126","author":"Guymer RH","year":"2019","unstructured":"Guymer RH, Wu Z, Hodgson LA, et al.. Subthreshold nanosecond laser intervention in age-related macular degeneration: the LEAD randomized controlled clinical trial. Ophthalmology. 2019, 126:829-38. 10.1016\/j.ophtha.2018.09.015","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2019.0868","article-title":"Imaging, genetic, and demographic factors associated with conversion to neovascular age-related macular degeneration: secondary analysis of a randomized clinical trial","volume":"137","author":"Hallak JA","year":"2019","unstructured":"Hallak JA, de Sisternes L, Osborne A, Yaspan B, Rubin DL, Leng T. Imaging, genetic, and demographic factors associated with conversion to neovascular age-related macular degeneration: secondary analysis of a randomized clinical trial. JAMA Ophthalmol. 2019, 137:738-44. 10.1001\/jamaophthalmol.2019.0868","journal-title":"JAMA Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2020.0724","article-title":"Effect of adjuvant topical dorzolamide-timolol vs placebo in neovascular age-related macular degeneration: a randomized clinical trial","volume":"138","author":"Hsu J","year":"2020","unstructured":"Hsu J, Patel SN, Wolfe JD, et al.. Effect of adjuvant topical dorzolamide-timolol vs placebo in neovascular age-related macular degeneration: a randomized clinical trial. JAMA Ophthalmol. 2020, 138:560-7. 10.1001\/jamaophthalmol.2020.0724","journal-title":"JAMA Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.06.038","article-title":"Retinal specialist versus artificial intelligence detection of retinal fluid from OCT: age-related eye disease study 2: 10-year follow-on study","volume":"128","author":"Keenan TD","year":"2021","unstructured":"Keenan TD, Clemons TE, Domalpally A, et al.. Retinal specialist versus artificial intelligence detection of retinal fluid from OCT: age-related eye disease study 2: 10-year follow-on study. Ophthalmology. 2021, 128:100-9. 10.1016\/j.ophtha.2020.06.038","journal-title":"Ophthalmology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2019.5540","article-title":"Efficacy of a treat-and-extend regimen with ranibizumab in patients with neovascular age-related macular disease: a randomized clinical trial","volume":"138","author":"Kertes PJ","year":"2020","unstructured":"Kertes PJ, Galic IJ, Greve M, Williams G, Baker J, Lahaie M, Sheidow T. Efficacy of a treat-and-extend regimen with ranibizumab in patients with neovascular age-related macular disease: a randomized clinical trial. JAMA Ophthalmol. 2020, 138:244-50. 10.1001\/jamaophthalmol.2019.5540","journal-title":"JAMA Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2020.04.016","article-title":"Agreement of spectral-domain OCT with fluorescein leakage in neovascular age-related macular degeneration: post hoc analysis of the HARBOR study","volume":"4","author":"Khurana RN","year":"2020","unstructured":"Khurana RN, Hill L, Ghanekar A, Gune S. Agreement of spectral-domain OCT with fluorescein leakage in neovascular age-related macular degeneration: post hoc analysis of the HARBOR study. Ophthalmol Retina. 2020, 4:1054-8. 10.1016\/j.oret.2020.04.016","journal-title":"Ophthalmol Retina"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84650-7","article-title":"Clustering of eyes with age-related macular degeneration or pachychoroid spectrum diseases based on choroidal thickness profile","volume":"11","author":"Kim YH","year":"2021","unstructured":"Kim YH, Lee B, Kang E, Oh J. Clustering of eyes with age-related macular degeneration or pachychoroid spectrum diseases based on choroidal thickness profile. Sci Rep. 2021, 11:4999. 10.1038\/s41598-021-84650-7","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003128","article-title":"Efficacy and safety of intravitreal aflibercept using a treat-and-extend regimen for neovascular age-related macular degeneration: the ARIES study: a randomized clinical trial","volume":"41","author":"Mitchell P","year":"2021","unstructured":"Mitchell P, Holz FG, Hykin P, et al.. Efficacy and safety of intravitreal aflibercept using a treat-and-extend regimen for neovascular age-related macular degeneration: the ARIES study: a randomized clinical trial. Retina. 2021, 41:1911-20. 10.1097\/IAE.0000000000003128","journal-title":"Retina"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-0807-2","article-title":"Phase I\/II randomized study of proton beam with anti-VEGF for exudative age-related macular degeneration: long-term results","volume":"34","author":"Mukkamala LK","year":"2020","unstructured":"Mukkamala LK, Mishra K, Daftari I, Moshiri A, Park SS. Phase I\/II randomized study of proton beam with anti-VEGF for exudative age-related macular degeneration: long-term results. Eye (Lond). 2020, 34:2271-9. 10.1038\/s41433-020-0807-2","journal-title":"Eye (Lond)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.05.016","article-title":"OCT risk factors for development of late age-related macular degeneration in the fellow eyes of patients enrolled in the HARBOR study","volume":"126","author":"Nassisi M","year":"2019","unstructured":"Nassisi M, Lei J, Abdelfattah NS, et al.. OCT risk factors for development of late age-related macular degeneration in the fellow eyes of patients enrolled in the HARBOR study. Ophthalmology. 2019, 126:1667-74. 10.1016\/j.ophtha.2019.05.016","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1089\/cell.2018.0045","article-title":"Suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with dry-type age-related macular degeneration and Stargardt's macular dystrophy: 6-month follow-up results of a phase 2 study","volume":"20","author":"Oner A","year":"2018","unstructured":"Oner A, Gonen ZB, Sevim DG, Smim Kahraman N, Unlu M. Suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with dry-type age-related macular degeneration and Stargardt's macular dystrophy: 6-month follow-up results of a phase 2 study. Cell Reprogram. 2018, 20:329-36. 10.1089\/cell.2018.0045","journal-title":"Cell Reprogram"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520931618","article-title":"Ranibizumab plus fufang xueshuantong capsule versus ranibizumab alone for exudative age-related macular degeneration","volume":"48","author":"Pan HT","year":"2020","unstructured":"Pan HT, Wang JJ, Huang JL, et al.. Ranibizumab plus fufang xueshuantong capsule versus ranibizumab alone for exudative age-related macular degeneration. J Int Med Res. 2020, 48:300060520931618. 10.1177\/0300060520931618","journal-title":"J Int Med Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01016-2","article-title":"Effects of Macuprev(\u00ae) supplementation in age-related macular degeneration: a double-blind randomized morpho-functional study along 6\u00a0months of follow-up","volume":"36","author":"Parravano M","year":"2019","unstructured":"Parravano M, Tedeschi M, Manca D, et al.. Effects of Macuprev(\u00ae) supplementation in age-related macular degeneration: a double-blind randomized morpho-functional study along 6\u00a0months of follow-up. Adv Ther. 2019, 36:2493-505. 10.1007\/s12325-019-01016-2","journal-title":"Adv Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81810-7","article-title":"Subthreshold laser treatment for reticular pseudodrusen secondary to age-related macular degeneration","volume":"11","author":"Querques G","year":"2021","unstructured":"Querques G, Sacconi R, Gelormini F, et al.. Subthreshold laser treatment for reticular pseudodrusen secondary to age-related macular degeneration. Sci Rep. 2021, 11:2193. 10.1038\/s41598-021-81810-7","journal-title":"Sci Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2017.03.015","article-title":"Machine learning to analyze the prognostic value of current imaging biomarkers in neovascular age-related macular degeneration","volume":"2","author":"Schmidt-Erfurth U","year":"2018","unstructured":"Schmidt-Erfurth U, Bogunovic H, Sadeghipour A, et al.. Machine learning to analyze the prognostic value of current imaging biomarkers in neovascular age-related macular degeneration. Ophthalmol Retina. 2018, 2:24-30. 10.1016\/j.oret.2017.03.015","journal-title":"Ophthalmol Retina"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.03.010","article-title":"Application of automated quantification of fluid volumes to anti-VEGF therapy of neovascular age-related macular degeneration","volume":"127","author":"Schmidt-Erfurth U","year":"2020","unstructured":"Schmidt-Erfurth U, Vogl WD, Jampol LM, Bogunovi\u0107 H. Application of automated quantification of fluid volumes to anti-VEGF therapy of neovascular age-related macular degeneration. Ophthalmology. 2020, 127:1211-9. 10.1016\/j.ophtha.2020.03.010","journal-title":"Ophthalmology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2020.1376","article-title":"Characterization of drusen and hyperreflective foci as biomarkers for disease progression in age-related macular degeneration using artificial intelligence in optical coherence tomography","volume":"138","author":"Waldstein SM","year":"2020","unstructured":"Waldstein SM, Vogl WD, Bogunovic H, Sadeghipour A, Riedl S, Schmidt-Erfurth U. Characterization of drusen and hyperreflective foci as biomarkers for disease progression in age-related macular degeneration using artificial intelligence in optical coherence tomography. JAMA Ophthalmol. 2020, 138:740-7. 10.1001\/jamaophthalmol.2020.1376","journal-title":"JAMA Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.02.025","article-title":"Characterizing new-onset exudation in the randomized phase 2 FILLY trial of complement inhibitor pegcetacoplan for geographic atrophy","volume":"128","author":"Wykoff CC","year":"2021","unstructured":"Wykoff CC, Rosenfeld PJ, Waheed NK, et al.. Characterizing new-onset exudation in the randomized phase 2 FILLY trial of complement inhibitor pegcetacoplan for geographic atrophy. Ophthalmology. 2021, 128:1325-36. 10.1016\/j.ophtha.2021.02.025","journal-title":"Ophthalmology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2021.06.010","article-title":"Self-supervised feature learning and phenotyping for assessing age-related macular degeneration using retinal fundus\u00a0images","volume":"6","author":"Yellapragada B","year":"2022","unstructured":"Yellapragada B, Hornauer S, Snyder K, Yu S, Yiu G. Self-supervised feature learning and phenotyping for assessing age-related macular degeneration using retinal fundus\u00a0images. Ophthalmol Retina. 2022, 6:116-29. 10.1016\/j.oret.2021.06.010","journal-title":"Ophthalmol Retina"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108196","article-title":"Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis","volume":"9","author":"Chen X","year":"2014","unstructured":"Chen X, Rong SS, Xu Q, et al.. Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis. PLoS One. 2014, 9:e108196. 10.1371\/journal.pone.0108196","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0707","article-title":"The association between diabetes and age-related macular degeneration among the elderly in Taiwan","volume":"41","author":"He MS","year":"2018","unstructured":"He MS, Chang FL, Lin HZ, Wu JL, Hsieh TC, Lee YC. The association between diabetes and age-related macular degeneration among the elderly in Taiwan. Diabetes Care. 2018, 41:2202-11. 10.2337\/dc18-0707","journal-title":"Diabetes Care"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182831248","article-title":"Ten-year incidence of age-related macular degeneration according to diabetic retinopathy classification among medicare beneficiaries","volume":"33","author":"Hahn P","year":"2013","unstructured":"Hahn P, Acquah K, Cousins SW, Lee PP, Sloan FA. Ten-year incidence of age-related macular degeneration according to diabetic retinopathy classification among medicare beneficiaries. Retina. 2013, 33:911-9. 10.1097\/IAE.0b013e3182831248","journal-title":"Retina"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1258\/jrsm.2009.080298","article-title":"Age-related macular degeneration","volume":"102","author":"Ayoub T","year":"2009","unstructured":"Ayoub T, Patel N. Age-related macular degeneration. J R Soc Med. 2009, 102:56-61. 10.1258\/jrsm.2009.080298","journal-title":"J R Soc Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2022.02.004","article-title":"Advanced retinal imaging and applications for clinical practice: a consensus review","volume":"67","author":"Fogel-Levin M","year":"2022","unstructured":"Fogel-Levin M, Sadda SR, Rosenfeld PJ, Waheed N, Querques G, Freund BK, Sarraf D. Advanced retinal imaging and applications for clinical practice: a consensus review. Surv Ophthalmol. 2022, 67:1373-90. 10.1016\/j.survophthal.2022.02.004","journal-title":"Surv Ophthalmol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30241","article-title":"A review of the usage and post-surgical outcomes of anesthesia for laser in situ keratomileusis (LASIK) procedure","volume":"14","author":"Riazi Esfahani P","year":"2022","unstructured":"Riazi Esfahani P, Reddy AJ, Sommer DA, et al.. A review of the usage and post-surgical outcomes of anesthesia for laser in situ keratomileusis (LASIK) procedure. Cureus. 2022, 14:e30241. 10.7759\/cureus.30241","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/129647-an-analysis-of-the-usage-of-retinal-imaging-technology-in-the-detection-of-age-related-macular-degeneration","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:27Z","timestamp":1707509007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/129647-an-analysis-of-the-usage-of-retinal-imaging-technology-in-the-detection-of-age-related-macular-degeneration"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.40527","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,16]]}}}